Syn-Tech Chem & Pharm Co (ROCO:1777) Piotroski F-Score: 6 (As of Jul. 21, 2026) — 14% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:1777 Syn-Tech Chem & Pharm Co Ltd ROCO:1777
73 GF Score
Price NT$72.80
GF Value NT$106.95
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Syn-Tech Chem & Pharm Co Piotroski F-Score?

Syn-Tech Chem & Pharm Co ROCO:1777 +0.41% 73 Piotroski F-Score is 6 as of Jul. 21, 2026, which is 14% below its 10-year median of 7.00. GuruFocus rates ROCO:1777 with a GF Score™ of 73/100 and a GF Value™ of NT$106.95 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 1,333 Biotechnology companies, Syn-Tech Chem & Pharm Co ranks better than 91.97% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Syn-Tech Chem & Pharm Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Syn-Tech Chem & Pharm Co's Piotroski F-Score or its related term are showing as below:

ROCO:1777' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 7   Max: 9
Current: 6

During the past 13 years, the highest Piotroski F-Score of Syn-Tech Chem & Pharm Co was 9. The lowest was 4. And the median was 7.

Syn-Tech Chem & Pharm Co  (ROCO:1777) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Syn-Tech Chem & Pharm Co Piotroski F-Score Related Terms


Syn-Tech Chem & Pharm Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Syn-Tech Chem & Pharm Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syn-Tech Chem & Pharm Co Piotroski F-Score Chart

Syn-Tech Chem & Pharm Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 7.00 5.00 8.00 6.00

Syn-Tech Chem & Pharm Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.00 8.00 6.00 6.00 6.00

ROCO:1777 vs VRTX, REGN, ALNY: Piotroski F-Score Comparison

For the Biotechnology subindustry, Syn-Tech Chem & Pharm Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syn-Tech Chem & Pharm Co Piotroski F-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syn-Tech Chem & Pharm Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Syn-Tech Chem & Pharm Co's Piotroski F-Score falls into.


ROCO:1777
73GF Score
Syn-Tech Chem & Pharm Co Ltd ROCO:1777
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Net Income was 75.751 + 16.611 + 77.367 + 91.88 = NT$262 Mil.
Cash Flow from Operations was 115.558 + 114.997 + 72.887 + 256.05 = NT$559 Mil.
Revenue was 315.75 + 324.84 + 336.706 + 322.945 = NT$1,300 Mil.
Gross Profit was 116.398 + 92.224 + 110.046 + 131.69 = NT$450 Mil.
Average Total Assets from the begining of this year (Dec24)
to the end of this year (Dec25) was
(2851.865 + 2894.62 + 2951.674 + 2700.439 + 2959.852) / 5 = NT$2871.69 Mil.
Total Assets at the begining of this year (Dec24) was NT$2,852 Mil.
Long-Term Debt & Capital Lease Obligation was NT$50 Mil.
Total Current Assets was NT$1,531 Mil.
Total Current Liabilities was NT$304 Mil.
Net Income was 87.384 + 98.603 + 116.021 + 91.276 = NT$393 Mil.

Revenue was 269.782 + 343.028 + 330.583 + 314.272 = NT$1,258 Mil.
Gross Profit was 104.847 + 143.707 + 108.373 + 130.014 = NT$487 Mil.
Average Total Assets from the begining of last year (Dec23)
to the end of last year (Dec24) was
(2900.891 + 2840.663 + 2785.182 + 2701.752 + 2851.865) / 5 = NT$2816.0706 Mil.
Total Assets at the begining of last year (Dec23) was NT$2,901 Mil.
Long-Term Debt & Capital Lease Obligation was NT$58 Mil.
Total Current Assets was NT$1,333 Mil.
Total Current Liabilities was NT$219 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Syn-Tech Chem & Pharm Co's current Net Income (TTM) was 262. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Syn-Tech Chem & Pharm Co's current Cash Flow from Operations (TTM) was 559. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec24)
=261.609/2851.865
=0.0917326

ROA (Last Year)=Net Income/Total Assets (Dec23)
=393.284/2900.891
=0.13557352

Syn-Tech Chem & Pharm Co's return on assets of this year was 0.0917326. Syn-Tech Chem & Pharm Co's return on assets of last year was 0.13557352. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Syn-Tech Chem & Pharm Co's current Net Income (TTM) was 262. Syn-Tech Chem & Pharm Co's current Cash Flow from Operations (TTM) was 559. ==> 559 > 262 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec24 to Dec25
=49.674/2871.69
=0.01729783

Gearing (Last Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=57.54/2816.0706
=0.02043273

Syn-Tech Chem & Pharm Co's gearing of this year was 0.01729783. Syn-Tech Chem & Pharm Co's gearing of last year was 0.02043273. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec25)=Total Current Assets/Total Current Liabilities
=1531.253/304.49
=5.02891064

Current Ratio (Last Year: Dec24)=Total Current Assets/Total Current Liabilities
=1333.32/219.471
=6.07515344

Syn-Tech Chem & Pharm Co's current ratio of this year was 5.02891064. Syn-Tech Chem & Pharm Co's current ratio of last year was 6.07515344. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Syn-Tech Chem & Pharm Co's number of shares in issue this year was 44.803. Syn-Tech Chem & Pharm Co's number of shares in issue last year was 44.817. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=450.358/1300.241
=0.34636502

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=486.941/1257.665
=0.38717862

Syn-Tech Chem & Pharm Co's gross margin of this year was 0.34636502. Syn-Tech Chem & Pharm Co's gross margin of last year was 0.38717862. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec24)
=1300.241/2851.865
=0.45592656

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec23)
=1257.665/2900.891
=0.43354438

Syn-Tech Chem & Pharm Co's asset turnover of this year was 0.45592656. Syn-Tech Chem & Pharm Co's asset turnover of last year was 0.43354438. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+0+1+0+1
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Syn-Tech Chem & Pharm Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 6 mean?
Syn-Tech Chem & Pharm Co (ROCO:1777) has a Piotroski F-Score of 6 as of Jul. 21, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Syn-Tech Chem & Pharm Co and its competitors. This is 14% below median its historical median of 7.00. Over the past decade, Syn-Tech Chem & Pharm Co's Piotroski F-Score has ranged from 4.00 to 9.00. According to the industry distribution chart, Syn-Tech Chem & Pharm Co ranks #107 out of 1333 companies in the Biotechnology industry, placing it in the top 8%.
Is Syn-Tech Chem & Pharm Co's Piotroski F-Score too high?
Syn-Tech Chem & Pharm Co's current Piotroski F-Score of 6 is 14% below median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 9.00. The Biotechnology industry median Piotroski F-Score is 3.00. Syn-Tech Chem & Pharm Co's value of 6 is 100% above this industry median. Based on the distribution chart, Syn-Tech Chem & Pharm Co ranks #107 out of 1333 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Syn-Tech Chem & Pharm Co has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Syn-Tech Chem & Pharm Co's Piotroski F-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Syn-Tech Chem & Pharm Co ranks #107 out of 1333 companies for Piotroski F-Score. This places Syn-Tech Chem & Pharm Co in the top 8% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 3.00. Syn-Tech Chem & Pharm Co's value of 6 is 100% above this benchmark. Historically, Syn-Tech Chem & Pharm Co's own Piotroski F-Score has ranged from 4.00 to 9.00 over the past decade. While the company's 10-year median is 7.00 vs. the industry median of 3.00, Syn-Tech Chem & Pharm Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Biotechnology company?
The median Piotroski F-Score among Biotechnology companies is 3.00, based on 1,333 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Syn-Tech Chem & Pharm Co's current Piotroski F-Score of 6 is 100% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Syn-Tech Chem & Pharm Co and its competitors. For the Biotechnology industry, the median Piotroski F-Score is 3.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Syn-Tech Chem & Pharm Co's current Piotroski F-Score is 6, which is 14% below median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syn-Tech Chem & Pharm Co stock overvalued right now?
Based on GuruFocus' analysis, Syn-Tech Chem & Pharm Co (ROCO:1777) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$106.95, compared to a current price of NT$72.80 — trading 31.9% below its estimated fair value. The current Piotroski F-Score is 6, which is 14% below median its 10-year median of 7.00 and 100% above the Biotechnology industry median of 3.00. Syn-Tech Chem & Pharm Co's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Syn-Tech Chem & Pharm Co (ROCO:1777), the current Piotroski F-Score is 6 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Syn-Tech Chem & Pharm Co (ROCO:1777) Overvalued in 2026?

Based on GuruFocus' analysis, Syn-Tech Chem & Pharm Co stock appears to be undervalued. The current stock price of NT$72.80 is trading 31.9% below its estimated GF Value™ of NT$106.95. GuruFocus considers Syn-Tech Chem & Pharm Co to be Significantly Undervalued.

Key valuation signals for ROCO:1777:

  • Piotroski F-Score: 6 (14% below median its 10-year median of 7.00)
  • GF Value™: NT$106.95 vs. price of NT$72.80 (31.9% below fair value)
  • GF Score™: 73/100 with 1 warning sign
  • Industry Position: 100% above the Biotechnology median (#107 of 1333)

No single metric tells the full story. See the ROCO:1777 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Syn-Tech Chem & Pharm Co Business Description

Address No. 168, Kai Yuan Road, Xinying District, Tainan City, TWN, 73055
Syn-Tech Chem & Pharm Co Ltd is engaged in the manufacture and sale of western medicines, veterinary drugs, food additives, cosmetics, and related businesses. It manufactures and sells Active Pharmaceutical Ingredients for domestic and foreign pharmaceutical companies and trade agents. Its products include Alfuzosin HCl, Atomoxetine HCl, Chlorzoxazone, Chlormezanone, Cloperastine HCl, Crotamiton, Diclofenac Epolamine, and others. It generates the majority of its revenue from Asia excluding Taiwan.
73GF Score

Get the complete analysis for ROCO:1777

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$72.80
Price
NT$106.95
GF Value